Roflumilast for asthma: Efficacy findings in non-placebo-controlled comparator and dosing studies

This publication has 16 references indexed in Scilit:

• Montelukast for prevention and treatment of asthma exacerbations in adults: Systematic review and meta-analysis
  Allergy and Asthma Proceedings, 2014
• International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
  European Respiratory Journal, 2013
• Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthma
  2012
• Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD
  Respiratory Research, 2011
• Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials
  The Lancet, 2009
• Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
  The Lancet, 2009
• Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD
  Thorax, 2007
• Efficacy and safety of roflumilast in the treatment of asthma
  Annals of Allergy, Asthma & Immunology, 2006
• Comparison of roflumilast, an oral anti‐inflammatory, with beclomethasone dipropionate in the treatment of persistent asthma
  Allergy, 2005
• Effect of long-term treatment with inhaled budesonide or theophylline on lung function, airway reactivity and asthma symptoms
  Respiratory Medicine, 2002